Here's Why Iran's Government Has Gotten Away With Tyranny
Trump Says He Is Concerned About the Midterm Elections
Don't Let Cea Weaver's Tears Fool You
Inside the Massachusetts Prison Where Women Live in Fear of 'Transgender' Inmates
Mamdani Voters Shrug at Venezuelan Immigrant's Warning Against Socialism
Guess Who Has Become a Propaganda Tool in Iran As the Regime Shuts...
Over a Dozen Oil Executives to Meet the President Trump As Venezuelan Oil...
The Gift of America and the Gift of Life
New York Man Indicted for Threatening to Kill Federal Agent and His Children
Texas Couple Convicted of Running $25M COVID-Era Pyramid Scheme That Defrauded 10,000 Vict...
Automakers Eat Billion-Dollar Losses on Electric Vehicles
Texas AG Ken Paxton Shuts Down Taxpayer Funded 'Abortion Tourism'
$500K Stolen, 20 States Targeted: Detroit Man Admits Wire Fraud and Identity Theft
DHS to Surge 1,000 Additional Agents Into Minneapolis As Protests Escalate
Oklahoma Chiropractor Indicted in $30M Health Care Fraud and COVID Relief Theft Scheme
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement